ORIOLA.HE Oriola

Healthcare Pharmaceutical Retailers Helsinki Exchange
0.7920 EUR
Close of Oct 29, 2026
0.7390 1.22
Market cap
EUR 146M
P/E
-
P/B
1.56x
ROE
-1.9%
Dividend yield
8.70%
Fundamental score
2.0/5

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ORIOLA.HE undervalued?

Graham number

The Graham number of Oriola cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Oriola fundamental analysis

8 of 21 checks passed

ROE 0/2

Low return on equity (-1.9%), below 10%.

ROA 0/1

Return on assets (-0.2%) is below the industry median (-0.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-33.3%) is below the industry median (-33.3%).

Revenue Growth 1/2

Revenue grew 7.4% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (32.7%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Cash Runway 2/2

Cash covers 2.2 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (1.6x) is below the industry median (1.6x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 2/2

Dividend yield (8.7%) is in the top 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Oriola stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Oriola

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs a…

Full company profile